Experts say Investors may be valuing AI companies too generously if health systems can’t justify the costs of these tools.

Discover how explainable AI (xAI) and real-world data (RWD) improve clinical decision-making in oncology by identifying key prognostic markers across multiple cancer types.

The results of the MASAI trial have already led to the adoption of AI-assisted mammography in several regional screening ...

OpenAI announced this week its AI research assistant, which it calls “ deep research .” Powered by OpenAI’s o3-mini model ...

One of the most agonizing experiences a cancer patient suffers is waiting without knowing: waiting for a diagnosis, waiting ...

First Focal One® procedure utilizing Cortechs.ai’s advanced MRI-imaging technology, OnQ Prostate, successfully performed at the University of ...

New research results now published from Lund University’s MASAI trial are even better than the initial findings from last ...

Onc.AI presented results at the Society for Immunotherapy of Cancer (SITC), showcasing a multi-institutional study demonstrating that Serial CTRS improved the prediction of overall survival for ...

A North Yorkshire hospital has introduced AI technology that could speed up the detection of lung cancer and other serious ...

Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, highlighting its potential in the early detection of diseases like type 2 diabetes ...

Revolutionary AI breast cancer screening trial launches across 30 UK sites, promising to tackle radiologist shortages and speed up diagnosis for 700,000 women.